The Well-Established Technology of Radiofrequency
Radiofrequency (RF) technology has long been a trusted tool in non-invasive aesthetic medicine. Its approval by the FDA in 2002 for monopolar radiofrequency set the stage for its widespread use, thanks to its proven efficacy and safety. Over the years, RF technology has evolved significantly, leading to the development of devices equipped with micro-needles that can penetrate the superficial dermis, thereby enhancing skin texture. The advent of endodermal radiofrequency represents a significant leap forward, pushing the boundaries of medical aesthetic treatments.
The Innovation Behind ATTIVA Radiofrequency
ATTIVA stands at the forefront of this evolution, born from eight years of rigorous scientific research and now FDA-approved. This cutting-edge technology employs radiofrequency in a unique endodermal process to effectively address skin laxity.
Precision with Specialized Cannulas
At the heart of ATTIVA’s innovation is the use of a neurosurgical cannula, designed to deliver energy deep into the dermis. This flexible yet resilient cannula ensures localized heat emission via its non-insulated tip, which enables controlled thermo-stimulation. The precision of this approach is vital, as it ensures uniform heat distribution across the targeted area, thereby stimulating fibroblasts and elastin. This process not only causes existing collagen fibers to contract but also stimulates new collagen production.
ATTIVA offers a variety of cannulas tailored to specific areas prone to skin laxity:
- **50 mm/22 Gauge**: Ideal for the forehead, eyelids, and upper lip.
- **100 mm/22 Gauge**: Best suited for the face, neck, and décolletage.
- **150 mm/20 Gauge**: Designed for the arms, peri-umbilical area, and knees.
- **200 mm/16 Gauge**: Perfect for the thighs.
Ensuring Safety with Double Temperature Verification
Safety is paramount in ATTIVA treatments, ensured by a double temperature verification system throughout the procedure. The cannula is equipped with an internal thermal probe to accurately measure the temperature deep within the epidermis, while an external thermography device monitors the skin's surface temperature in real-time. This dual monitoring guarantees that the treatment remains within optimal temperature ranges, thus preventing burns or damage to the skin's essential structures.
Targeting Elastin for Optimal Results
The key to ATTIVA’s effectiveness lies in its ability to activate elastin while maintaining its structural integrity. Achieving this requires maintaining a precise average temperature of 48 degrees Celsius during the treatment.
Proven Results Through Rigorous Testing
In collaboration with the CRISMENC (Center for Research and Development in Aesthetic Medicine of the University of Sassari) and the University of Verona, comprehensive studies were conducted to evaluate the structural and biological changes induced by ATTIVA. In vivo biopsies from consenting subjects revealed significant improvements in tissue quality, including increased firmness and reduced ptosis, without any signs of necrosis or scar fibrosis. These results were not only immediate but also long-lasting, persisting for several months.
Clinical Outcomes and Patient Satisfaction
Clinical observations have shown that patients benefit from more than just skin tightening. Post-treatment, patients reported improved facial contour definition, enhanced skin quality, and a brighter complexion. Recovery was swift, with no need for extended social downtime. Improvements continue to manifest for up to six months post-treatment, with an annual maintenance session recommended to sustain results.
While endodermal radiofrequency may not replace the results of a surgical facelift, ATTIVA presents itself as a highly effective and minimally invasive alternative for those dealing with moderate skin laxity.
댓글